NASHPHARM
1Patents
1Active
1Granted
39Portfolio score
Filing activity: Sep 28, 2017 → Sep 28, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11185520B2 | Composition comprising at least one water-soluble pharmaceutically acceptable salt of elafibranor having improved intestinal absorption | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.